임상

HOME > 연구실적 > 임상 > 논문
 
작성일 : 18-05-28 14:25
논문번호 200
논문제목(영문) Differences in the Korea Acute Myocardial Infarction Registry Compared with Western Registries
국내외구분 국내 SCI여부 SCI(E)
연구책임자역할 교신저자
주저자명 Sim DS
교신저자명 Jeong MH
공동저자명 Sim DS, Jeong MH
게제년월일 2017-11-01
ISSN 1738-5520
Impact Factor 1.252
학술지명 Korean circulation journal
서지사항 0집 / 47권 / 6호,   페이지(811 - 822)
요약초록문
(Abstract) 입력
The Korea Acute Myocardial Infarction Registry (KAMIR) is the first nationwide registry that reflects current therapeutic approaches and acute myocardial infarction (AMI) management in Korea. The results of the KAMIR demonstrated different risk factors and responses to medical and interventional treatments. The results indicated that the incidence of ST-elevation myocardial infarction (STEMI) was relatively high, and that the prevalence of dyslipidemia was relatively low with higher triglyceride and lower high-density lipoprotein cholesterol levels. Percutaneous coronary intervention (PCI) rates were high for both STEMI and non-ST-elevation myocardial infarction (NSTEMI) with higher use of drug-eluting stents (DESs). DES were effective and safe without increased risk of stent thrombosis in Korean AMI patients. Triple antiplatelet therapy, consisting of aspirin, clopidogrel, and cilostazol, was effective in preventing adverse clinical outcomes after PCI. Statin therapy was effective in Korean AMI patients, including those with very low levels of low-density lipoprotein cholesterol and those with cardiogenic shock. The KAMIR score had a greater predictive value than Thrombolysis in Myocardial Infarction (TIMI) and Global Registry of Acute Coronary Events (GRACE) scores for long-term mortality in AMI patients. Based on these results, the KAMIR will be instrumental for establishing new therapeutic strategies and effective methods for secondary prevention of AMI and guidelines for Asian patients.
파일  C-200 Differences in the Korea Acute Myocardial Infarction Registry Compared with Western Registries..pdf (419.3K) DATE : 2018-05-28 14:25:21